Cyclophosphamide, bortezomib and dexamethasone induction for newly diagnosed multiple myeloma: high response rates in a phase II clinical trial
Reeder, C B, Reece, D E, Kukreti, V, Chen, C, Trudel, S, Hentz, J, Noble, B, Pirooz, N A, Spong, J E, Piza, J G, Zepeda, V H J, Mikhael, J R, Leis, J F, Bergsagel, P L, Fonseca, R, Stewart, A K
Published in Leukemia (01.07.2009)
Published in Leukemia (01.07.2009)
Get full text
Journal Article
Nondiffractive subwavelength wave beams in a medium with externally controlled anisotropy
Schneider, T, Serga, A A, Chumak, A V, Sandweg, C W, Trudel, S, Wolff, S, Kostylev, M P, Tiberkevich, V S, Slavin, A N, Hillebrands, B
Published in Physical review letters (14.05.2010)
Published in Physical review letters (14.05.2010)
Get more information
Journal Article
Clioquinol inhibits the proteasome and displays preclinical activity in leukemia and myeloma
Mao, X, Li, X, Sprangers, R, Wang, X, Venugopal, A, Wood, T, Zhang, Y, Kuntz, D A, Coe, E, Trudel, S, Rose, D, Batey, R A, Kay, L E, Schimmer, A D
Published in Leukemia (01.03.2009)
Published in Leukemia (01.03.2009)
Get full text
Journal Article
Treatment outcomes in patients with relapsed and refractory multiple myeloma and high-risk cytogenetics receiving single-agent carfilzomib in the PX-171-003-A1 study
Jakubowiak, A J, Siegel, D S, Martin, T, Wang, M, Vij, R, Lonial, S, Trudel, S, Kukreti, V, Bahlis, N, Alsina, M, Chanan-Khan, A, Buadi, F, Reu, F J, Somlo, G, Zonder, J, Song, K, Stewart, A K, Stadtmauer, E, Harrison, B L, Wong, A F, Orlowski, R Z, Jagannath, S
Published in Leukemia (01.12.2013)
Published in Leukemia (01.12.2013)
Get full text
Journal Article
Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure
St Bernard, R, Chodirker, L, Masih-Khan, E, Jiang, H, Franke, N, Kukreti, V, Tiedemann, R, Trudel, S, Reece, D, Chen, C I
Published in Bone marrow transplantation (Basingstoke) (01.01.2015)
Published in Bone marrow transplantation (Basingstoke) (01.01.2015)
Get full text
Journal Article
Shape-controlled MnO nanoparticles as T1 MRI contrast agents
Banerjee, A., Zeng, W., Taheri, M., Blasiak, B., Tomanek, B., Trudel, S.
Published in AIP advances (01.12.2019)
Published in AIP advances (01.12.2019)
Get full text
Journal Article
CyBorD induction therapy in clinical practice
Areethamsirikul, N, Masih-Khan, E, Chu, C-M, Jimenez-Zepeda, V, Reece, D E, Trudel, S, Kukreti, V, Tiedemann, R, Chen, C
Published in Bone marrow transplantation (Basingstoke) (01.03.2015)
Published in Bone marrow transplantation (Basingstoke) (01.03.2015)
Get full text
Journal Article
P962: CHANGE IN SOLUBLE BCMA LEVEL MAY BE A SURROGATE MARKER OF EARLY RESPONSE TO THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): PRELIMINARY RESULTS FROM A PHASE I STUDY OF CEVOSTAMAB
Nakamura, R., Hendricks, R., Dokhaei, R., Susilo, M., Wilson, D., Trudel, S., Cohen, A., Harrison, S. J., Krishnan, A., Fonseca, R., Adamkewicz, J. I., Li, M., Wong, C., Cooper, J., Sumiyoshi, T.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
PB2034: CAMMA 1: A MULTICENTER PHASE IB TRIAL EVALUATING THE SAFETY, PHARMACOKINETICS AND ACTIVITY OF CEVOSTAMAB‐CONTAINING REGIMENS IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Vij, R., Schade, H., Trudel, S., Chang, A. C., Huang, J., Samineni, D., Sumiyoshi, T., Tsai, J., Wong, T., Harrison, S. J.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P31 SINGLE‐AGENT BELANTAMAB MAFODOTIN IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA: FINAL ANALYSIS OF THE DREAMM‐2 TRIAL
Nooka, A., Cohen, A., Lee, H., Badros, A., Suvannasankha, A., Callander, N., Abdallah, A., Trudel, S., Chari, A., Libby, E., Chaudhry, M., Hultcrantz, M., Kortüm, K.M., Richardson, P., Popat, R., Sborov, D., Hakim, S., Lewis, E., Bhushan, B., Gorsh, B., Gupta, I., Opalinska, J., Lonial, S.
Published in HemaSphere (09.05.2023)
Published in HemaSphere (09.05.2023)
Get full text
Journal Article
Synthesis, characterization, and application of Fe3O4 Ag magnetic composites for mercury removal from water
Elhouderi, Z A, Beesley, D P, Nguyen, T T, Lai, P, Sheehan, K, Trudel, S, Prenner, E, Cramb, D T, Anikovskiy, M
Published in Materials research express (18.04.2016)
Published in Materials research express (18.04.2016)
Get full text
Journal Article
P897: UPDATED RESULTS FROM THE ONGOING PHASE 1 STUDY OF ELRANATAMAB, A BCMA TARGETED T‐CELL REDIRECTING IMMUNOTHERAPY, FOR PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Dalovisio, A., Bahlis, N., Raje, N., Costello, C., Dholaria, B., Solh, M., Levy, M., Tomasson, M., Dube, H., Damore, M., Jiang, S., Basu, C., Skoura, A., Chan, E., Trudel, S., Jakubowiak, A., Chu, M., Gasparetto, C., Sebag, M., Lesokhin, A.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM‐4 STUDY
Suvannasankha, A., Bahlis, N., Trudel, S., Weisel, K., Koenecke, C., Oriol, A., Voorhees, P. M., Alonso, A. A., Callander, N. S., Mateos Manteca, M. V., Reddy, N., Hakim, S., Patel, N., Williams, D., Jewell, R. C., Zhou, X., Gupta, I., Nooka, A. K.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P13: CAN PATIENT‐REPORTED OCULAR SYMPTOMS GUIDE DOSE MODIFICATIONS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING BELANTAMAB MAFODOTIN?
Popat, R, Badros, A, Kumar, S, Rodriguez‐Otero, P, Cohen, A, Manier, S, Voorhees, P, Gay, F, Rifkin, R, Martin, T, Chari, A, Weisel, K, Farooq, A, Jeng, B, Chng, W, Lee, H, Berdeja, J, Jadhav, V, Tosolini, A, Eliason, L, Palumbo, A, Dimopoulos, M, Lonial, S, Trudel, S, Richardson, P, Terpos, E
Published in HemaSphere (01.04.2022)
Published in HemaSphere (01.04.2022)
Get full text
Journal Article
Clinical Outcomes in t(4;14) Multiple Myeloma: A Chemotherapy-Sensitive Disease Characterized by Rapid Relapse and Alkylating Agent Resistance
Jaksic, Wilfrid, Trudel, Suzanne, Chang, Hong, Trieu, Young, Qi, Xi, Mikhael, Joseph, Reece, Donna, Chen, Christine, Stewart, A Keith
Published in Journal of clinical oncology (01.10.2005)
Published in Journal of clinical oncology (01.10.2005)
Get full text
Journal Article
EFFICACY AND SAFETY OF ELRANATAMAB (PF-06863135), A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Solh, M, Bahlis, NJ, Raje, NS, Costello, CL, Dholaria, B, Levy, MY, Tomasson, MH, Dube, H, Damore, MA, Lon, HK, Basu, C, Skoura, A, Chan, EM, Trudel, S, Jakubowiak, A, Chu, MP, Gasparetto, C, Dalovisio, A, Sebag, M, Lesokhin, AM
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Published in Hematology, Transfusion and Cell Therapy (01.10.2021)
Get full text
Journal Article
Altered gene expression in cells from patients with lysosomal storage disorders suggests impairment of the ubiquitin pathway
Bifsha, P, Landry, K, Ashmarina, L, Durand, S, Seyrantepe, V, Trudel, S, Quiniou, C, Chemtob, S, Xu, Y, Gravel, R A, Sladek, R, Pshezhetsky, A V
Published in Cell death and differentiation (01.03.2007)
Published in Cell death and differentiation (01.03.2007)
Get full text
Journal Article
Outcome of t(4;14) in Multiple Myeloma – Princess Margaret Cancer Centre Experience Over the Last 10 Years
Kukreti, V, Maganti, M, Reece, D, Masih-Khan, E, Jimenez-Zepeda, V.H, Trudel, S, Chen, C, Tiedemann, R, Farooki, S
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article